Oscar Health, Inc.
Oscar Health, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 4,076 | 4,805 | 2,774 | 2,149 | 2,599 | 2,237 | 1,527 | 1,206 | 2,268 | 2,231 | 1,870 | 1,400 | |||||
Short Term Investments | - | - | - | - | - | - | 624 | - | - | - | 690 | - | |||||
Available For Sale Securities Debt Securities Curr… | 4,480 | 1,995 | 1,216 | 888 | 938 | 751 | 624 | 504 | 364 | 616 | 690 | 1,044 | |||||
Premiums And Other Receivables Net | - | - | 443 | 445 | 465 | 489 | 316 | 301 | 398 | 343 | 201 | 207 | |||||
Accounts Receivable Net Current | 380 | 587 | - | - | - | - | - | - | - | - | - | - | |||||
Reinsurance Recoverables On Paid And Unpaid Losses | 197 | 142 | 100 | 159 | 193 | 188 | 292 | 273 | 241 | 243 | 241 | 278 | |||||
Other Assets Current | 60 | 26 | 24 | 29 | 30 | 23 | 21 | 21 | 16 | 9 | 7 | 8 | |||||
Assets Current | 9,373 | 7,777 | 4,613 | 3,763 | 4,313 | 3,775 | 2,845 | 2,368 | 3,359 | 3,504 | 3,061 | 2,992 | |||||
Property Plant And Equipment Net | 101 | 94 | 88 | 83 | 78 | 72 | 67 | 67 | 64 | 61 | 62 | 62 | |||||
Available For Sale Securities Debt Securities Nonc… | 1,601 | 1,267 | 1,471 | 1,751 | 1,846 | 1,873 | 1,815 | 1,934 | 1,466 | 737 | 365 | 180 | |||||
Long Term Investments | - | - | - | - | - | - | 1,815 | - | - | - | 365 | - | |||||
Restricted Cash And Investments Noncurrent | 29 | 29 | 33 | 28 | 31 | 31 | 31 | 30 | 30 | 30 | 30 | 27 | |||||
Other Assets Noncurrent | 122 | 123 | 120 | 121 | 116 | 94 | 82 | 84 | 87 | 87 | 83 | 89 | |||||
Assets | 11,227 | 9,290 | 6,325 | 5,746 | 6,384 | 5,844 | 4,840 | 4,483 | 5,006 | 4,419 | 3,601 | 3,350 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liability For Claims And Claims Adjustment Expense | 1,898 | 1,734 | 1,455 | 1,564 | 1,552 | 1,466 | 1,357 | 1,357 | 1,252 | 1,248 | 966 | 910 | |||||
Accounts Payable And Accrued Liabilities Current | 526 | 506 | 650 | 557 | 584 | 634 | 432 | 395 | 348 | 303 | 273 | 260 | |||||
Unearned Premiums | 168 | 172 | 166 | 77 | 69 | 71 | 74 | 66 | 60 | 66 | 66 | 72 | |||||
Liability For Future Policy Benefits | - | - | - | - | - | - | 0 | 1 | 3 | 4 | 6 | 0 | |||||
Reinsurance Payable | 3 | 5 | 4 | 7 | 13 | 24 | 41 | 51 | 60 | 62 | 61 | 67 | |||||
Liabilities Current | 8,690 | 7,140 | 4,863 | 3,977 | 4,866 | 4,149 | 3,463 | 2,955 | 3,502 | 3,019 | 2,429 | 2,061 | |||||
Long Term Debt Noncurrent | 432 | 431 | 430 | 686 | 300 | 300 | 300 | 299 | 299 | 299 | 299 | 299 | |||||
Other Liabilities Noncurrent | 50 | 51 | 52 | 56 | 57 | 59 | 61 | 64 | 65 | 66 | 68 | 69 | |||||
Liabilities | 9,172 | 7,623 | 5,345 | 4,719 | 5,223 | 4,508 | 3,824 | 3,318 | 3,866 | 3,385 | 2,795 | 2,428 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Treasury Stock Value | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | |||||
Treasury Stock Common Value | - | - | - | - | - | - | - | - | - | - | -3 | - | |||||
Additional Paid In Capital | 4,317 | 4,277 | 4,257 | 3,952 | 3,952 | 3,902 | 3,870 | 3,837 | 3,787 | 3,737 | 3,682 | 3,654 | |||||
Retained Earnings Accumulated Deficit | -2,254 | -2,615 | -3,294 | -2,942 | -2,804 | -2,576 | -2,851 | -2,698 | -2,643 | -2,699 | -2,877 | -2,727 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -8 | 5 | 18 | 16 | 14 | 10 | -2 | 26 | -3 | -3 | 1 | -4 | |||||
Stockholders Equity | 2,052 | 1,667 | 981 | 1,024 | 1,161 | 1,333 | 1,016 | 1,165 | 1,141 | 1,032 | 804 | 919 | |||||
Minority Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | |||||
Liabilities And Stockholders Equity | 11,227 | 9,290 | 6,325 | 5,746 | 6,384 | 5,844 | 4,840 | 4,483 | 5,006 | 4,419 | 3,601 | 3,350 | |||||
Common Class A | - | 266 | 262 | 6 | 5 | 218 | 0 | 6 | 6 | 200 | 0 | 4 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Class B | - | 36 | 36 | 0 | 0 | 36 | 0 | 0 | 0 | 36 | 0 | 0 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | - | 83 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Allowance For Doubtful Accounts Receivable Current | 55 | 7 | - | - | - | - | - | - | - | - | - | - | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.52% | 42.74% | 35.07% | - | - | - | - | - | - | - | - | - |
| 2025 | -19.11% | 19.64% | -15.30% | 9.89% | 21.50% | 27.24% | 8.51% | -9.96% | -5.31% | 3.13% | -11.18% | 37.78% |
| 2024 | 0.96% | -19.98% | -19.98% | 9.58% | 25.69% | -3.05% | 27.05% | 1.17% | 22.07% | -17.73% | -21.78% | 6.47% |
| 2023 | - | - | - | -17.65% | -30.29% | -39.30% | 27.04% | 38.22% | 88.37% | -19.84% | -21.10% | -1.26% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.08 | 1.09 | 0.95 | 0.95 | 0.89 | 0.91 | 0.82 | 0.80 | 0.96 | 1.16 | 1.26 | 1.45 | |||||
| Quick Ratio | 1.08 | 1.09 | 0.95 | 0.95 | 0.89 | 0.91 | 0.82 | 0.80 | 0.96 | 1.16 | 1.26 | 1.45 | |||||
| Working Capital | 683.68M | 636.95M | -249.18M | -214.31M | -552.34M | -374.08M | -618.06M | -586.72M | -142.65M | 484.37M | 632.09M | 930.75M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 4.47 | 4.57 | 5.45 | 4.61 | 4.50 | 3.38 | 3.76 | 2.85 | 3.39 | 3.28 | 3.47 | 2.64 | |||||
| Interest Coverage TTM | 34.90 | 0.55 | -20.02 | -8.51 | -5.47 | 7.09 | 2.41 | 2.49 | 2.05 | -1.01 | -9.58 | -12.75 | |||||
| Debt Ratio | 0.82 | 0.82 | 0.84 | 0.82 | 0.82 | 0.77 | 0.79 | 0.74 | 0.77 | 0.77 | 0.78 | 0.72 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.76 | 0.62 | 0.01 | 1.50 | 1.35 | 1.37 | 2.17 | 0.38 | 0.61 | 0.16 | 0.01 | 0.51 | |||||
| Days Sales Outstanding TTM | 23.07 | 42.03 | 4,841.49 | 17.71 | 20.51 | 21.56 | 10.28 | 62.90 | 37.11 | 139.10 | 3,570.38 | 39.28 | |||||
| Receivables Turnover TTM | 15.82 | 8.68 | 0.08 | 20.61 | 17.79 | 16.93 | 35.49 | 5.80 | 9.83 | 2.62 | 0.10 | 9.29 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 1.65 | -0.12 | -1.69 | -0.94 | -0.63 | 0.40 | 0.10 | 0.12 | 0.06 | -0.18 | -1.22 | -1.55 | |||||
| Free Cash Flow Per Share TTM | 8.73 | 9.39 | 4.03 | -0.52 | 1.30 | 4.74 | 3.95 | 3.71 | 1.06 | -0.33 | -1.34 | -1.99 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | -82.88% | -135.24% | -34,940.13% | -23.10% | -15.58% | -14.18% | 36.98% | -152.85% | 40.62% | 96.49% | -15.22% | 98.75% | |||||
| Operating Profit Margin TTM | 9.42% | 0.23% | -1,386.20% | -2.74% | -1.68% | 2.40% | 0.62% | 4.04% | 1.71% | -3.56% | -1,103.43% | -15.92% | |||||
| Net Profit Margin TTM | 8.23% | -0.85% | -1,549.86% | -3.17% | -2.10% | 1.75% | 0.28% | 1.99% | 0.63% | -7.71% | -1,267.24% | -17.67% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -12.97% | -33.64% | -99.69% | 421.89% | 164.22% | 914.39% | 42,880.21% | -24.96% | 435.98% | 24.38% | -65.02% | 303.23% | |||||
| Net Income Growth (1Y) | -441.71% | -132.13% | -1,842.49% | -931.12% | -982.76% | -330.83% | -109.40% | -108.46% | -103.85% | -90.63% | -55.37% | -40.10% | |||||
| EPS Growth (1Y) | -388.92% | -127.07% | -1,696.38% | -879.29% | -924.52% | -312.61% | -108.67% | -107.77% | -103.54% | -91.22% | -57.22% | -42.86% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 15.66 | -86.24 | -8.51 | -20.11 | -34.00 | 26.68 | 127.04 | 175.63 | 206.88 | -64.35 | -7.50 | -3.58 | |||||
| P/B TTM | 4.20 | 2.05 | 3.84 | 4.79 | 4.72 | 2.47 | 3.18 | 4.42 | 3.31 | 3.33 | 2.52 | 1.35 | |||||
| P/S TTM | 1.29 | 0.73 | 131.87 | 0.64 | 0.71 | 0.47 | 0.35 | 3.50 | 1.30 | 4.96 | 94.98 | 0.63 | |||||
| Market Cap | 8.62B | 3.42B | 3.77B | 4.91B | 5.48B | 3.29B | 3.23B | 5.16B | 3.78B | 3.44B | 2.03B | 1.24B | |||||
| Enterprise Value | 4.95B | -978.20M | 1.40B | 3.42B | 3.16B | 1.36B | 1.98B | 4.22B | 1.78B | 1.49B | 434.95M | 119.69M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 2.64B | 2.80B | 1.06B | -133.87M | 332.08M | 1.19B | 950.30M | 901.06M | 253.02M | -76.66M | -297.74M | -444.24M | |||||
| Net Debt | -3.67B | -4.40B | -2.37B | -1.49B | -2.32B | -1.94B | -1.25B | -932.57M | -1.99B | -1.95B | -1.59B | -1.12B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Oscar Health, Inc. (OSCR) — SEC Financial Statements & Analysis
Oscar Health, Inc. (OSCR) is a hospital & medical service plans company, incorporated in DE. Oscar Health, Inc. trades on NYSE as: OSCR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Oscar Health, Inc. reported a -12.97% year-over-year revenue growth, a Gross Profit Margin of -82.88% (TTM), a Debt-to-Equity ratio of 4.47x, a Price-to-Sales (P/S) ratio of 1.29x (TTM), a Price-to-Book (P/B) ratio of 4.20x (TTM), at a market cap of $8.62B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -12.97%
- Gross Profit Margin TTM
- -82.88%
- Debt To Equity
- 4.47x
- P/S TTM
- 1.29x
- P/B TTM
- 4.20x
- Market Cap
- $8.62B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Oscar Health, Inc. in?
Oscar Health, Inc. (OSCR) operates in the Hospital & Medical Service Plans industry.
What is OSCR's market cap?
Oscar Health, Inc. (OSCR) has a market capitalization of $8.62B as of 2026-06-30.
What is OSCR's P/E ratio?
Oscar Health, Inc. (OSCR)'s trailing twelve month P/E ratio is 15.66x as of 2026-06-30.
What exchange does OSCR trade on?
Oscar Health, Inc. (OSCR) trades on the NYSE.
Where is Oscar Health, Inc. incorporated?
Oscar Health, Inc. is incorporated in DE.